<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015904"><a href="http://purl.obolibrary.org/obo/MONDO_0015904">MONDO:0015904</a></h3>
<p><strong>Label:</strong> rare hypolipidemia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018999">MONDO:0018999</a> (LCAT deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0017774">MONDO:0017774</a> (hypobetalipoproteinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017773">MONDO:0017773</a> (hypoalphalipoproteinemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_650">Orphanet:650</a>, <a href="http://www.orpha.net/ORDO/Orphanet_31153">Orphanet:31153</a>, <a href="http://www.orpha.net/ORDO/Orphanet_31154">Orphanet:31154</a>, <a href="http://purl.obolibrary.org/obo/OMIM_136120">OMIM:136120</a>, <a href="http://purl.obolibrary.org/obo/OMIM_245900">OMIM:245900</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007759">HP:0007759</a> (Opacification of the corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000481">HP:0000481</a> (Abnormality of the cornea) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003077">HP:0003077</a> (Hyperlipidemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003077">HP:0003077</a> (Hyperlipidemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003077">HP:0003077</a> (Hyperlipidemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007759">HP:0007759</a> (Opacification of the corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003077">HP:0003077</a> (Hyperlipidemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002155">HP:0002155</a> (Hypertriglyceridemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002155">HP:0002155</a> (Hypertriglyceridemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002155">HP:0002155</a> (Hypertriglyceridemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0007759">HP:0007759</a> (Opacification of the corneal stroma) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002155">HP:0002155</a> (Hypertriglyceridemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) and <a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000481">HP:0000481</a> (Abnormality of the cornea) and <a href="http://purl.obolibrary.org/obo/HP_0003077">HP:0003077</a> (Hyperlipidemia) and <a href="http://purl.obolibrary.org/obo/HP_0003233">HP:0003233</a> (Decreased circulating high-density lipoprotein levels) 70.00%</li>
</ul>
</body>
</html>
